These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8376876)

  • 1. Plasma fibronectin and serum complement C3 levels in chronic active hepatitis following virus "B" versus virus "C" infection.
    Abdel Rahman MM; el Nasr MS; Mahmoud SA; Soliman A; Salama MM
    J Egypt Soc Parasitol; 1993 Aug; 23(2):579-89. PubMed ID: 8376876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cholesterol and chronic hepatitis C.
    Maggi G; Bottelli R; Gola D; Perricone G; Posca M; Zavaglia C; Ideo G
    Ital J Gastroenterol; 1996; 28(8):436-40. PubMed ID: 9032585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection.
    Feinman SV; Berris B; Fay O; Sooknanan R; Tanno HE; Tung WW; Lieberman HM
    Clin Invest Med; 1988 Aug; 11(4):286-91. PubMed ID: 3168350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibronectin in acute and chronic hepatitis].
    Malaia LT; Babak OIa; Iabluchanskiĭ NI; Sharov EI
    Klin Med (Mosk); 1990 Nov; 68(11):37-9. PubMed ID: 2283810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma fibronectin in chronic liver diseases].
    Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
    Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement C3 and C4 levels in serum from acute viral hepatitis].
    Ozer FT; Barut A; Inal A; Hacibektaşoğlu A
    Mikrobiyol Bul; 1992 Oct; 26(4):314-9. PubMed ID: 1435361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The behavior of lipids in acute viral hepatitis and chronic hepatopathies].
    Boroń-Kaczmarska A; Lapiński W
    Z Gesamte Inn Med; 1988 May; 43(9):225-8. PubMed ID: 3136599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ; Liaw YF
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of indicators of the kallikrein-kinin system of the blood and C 3 component of the complement in chronic viral hepatitis].
    Antonova TV; Iazov IaCh
    Klin Med (Mosk); 1989 May; 67(5):98-100. PubMed ID: 2770218
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study.
    Villari D; Pernice M; Spinella S; Squadrito G; Rodinò G; Brancatelli S; Longo G; Raimondo G
    Am J Gastroenterol; 1995 Jun; 90(6):955-8. PubMed ID: 7771429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic HB virus hepatitis in children. A study of 29 cases].
    Maggiore G; Marzani D; De Giacomo C; Sessa F; Civardi G; Scotta MS
    Sem Hop; 1984 May; 60(19):1349-52. PubMed ID: 6326326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].
    Bacq Y; Schillio Y; Brechot JF; De Muret A; Dubois F; Metman EH
    Gastroenterol Clin Biol; 1993; 17(5):364-9. PubMed ID: 8349072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic reactivity of the skin in chronic hepatitis].
    Fuchs H
    Ann Acad Med Stetin; 1990; 36():61-75. PubMed ID: 2099109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ursodeoxycholic hemisuccinate in the treatment of chronic active hepatitis. A controlled clinico-therapeutic study].
    Buzzelli G; Moscarella S; Focardi G; Dattolo P; Giusti A; Calviani L; Relli P; Gentilini P
    Minerva Med; 1992 Sep; 83(9):537-40. PubMed ID: 1436604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor necrosis factor and interleukin 6 in hepatitis C virus infection].
    Ren H; Zheng DF; Jia XP
    Zhonghua Nei Ke Za Zhi; 1992 Jun; 31(6):344-6, 381. PubMed ID: 1286584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
    Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.